Literature DB >> 10987305

The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.

G Liang1, K D Robertson, C Talmadge, J Sumegi, P A Jones.   

Abstract

A DNA fragment frequently hypermethylated in tumor cells was isolated using a novel screening strategy termed methylation-sensitive arbitrarily primed PCR. The isolated sequence corresponded to a CpG island at the 5' end of a previously unknown gene, TPEF (transmembrane protein containing epidermal growth factor and follistatin domains). Expression of TPEF was observed using Northern master blot analysis of a variety of normal tissues including colon, bladder, and prostate tissue. TPEF maps to human chromosome 2q33, where frequent loss of heterozygosity is seen in various human tumors, and TPEF was not expressed in most human colon and various other tumor cell lines examined by reverse transcription-PCR. Nine of 11 tumor cell lines were highly methylated in the 5' region and the first exon of the gene that demonstrated features characteristic of a CpG island. However the other two cell lines, which expressed TPEF, were hypomethylated in the 5' end of the gene. The region was also hypermethylated in 11 of 16 primary bladder tumors and in 3 of 4 primary colon tumors when compared with adjacent normal tissue. Our results suggest that potential tumor suppressor genes can be isolated from human tumors by virtue of their altered methylation patterns.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987305

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Tomoregulin internalization confers selective cytotoxicity of immunotoxins on prostate cancer cells.

Authors:  Xiao-Yan Zhao; Hsiao-Lai Liu; Bing Liu; Joerg Willuda; Gerhard Siemeister; Mithra Mahmoudi; Harald Dinter
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

2.  Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.

Authors:  Min Chen; Mala Sinha; Bruce A Luxon; Anne R Bresnick; Kathleen L O'Connor
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

3.  Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers.

Authors:  Matthias P A Ebert; Suzanne H Mooney; Lori Tonnes-Priddy; Joe Lograsso; Juliane Hoffmann; Jie Chen; Christoph Röcken; Hans-Ulrich Schulz; Peter Malfertheiner; Catherine Lofton-Day
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

4.  Generation and characterization of Tmeff2 mutant mice.

Authors:  Tian Rui Chen; Ping Wang; Liberty K Carroll; Ying-jiu Zhang; Bao-Xia Han; Fan Wang
Journal:  Biochem Biophys Res Commun       Date:  2012-07-22       Impact factor: 3.575

5.  Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.

Authors:  Su Man Lee; Jae Yong Park; Dong Sun Kim
Journal:  Mol Cells       Date:  2012-07-18       Impact factor: 5.034

Review 6.  Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer.

Authors:  M Widschwendter; J Berger; H M Müller; A G Zeimet; C Marth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

Review 7.  DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer.

Authors:  Johanna K Samuelsson; Sergio Alonso; Fumiichiro Yamamoto; Manuel Perucho
Journal:  Mutat Res       Date:  2010-09-17       Impact factor: 2.433

8.  A combined HM-PCR/SNuPE method for high sensitive detection of rare DNA methylation.

Authors:  Sascha Tierling; Matthias Schuster; Reimo Tetzner; Jörn Walter
Journal:  Epigenetics Chromatin       Date:  2010-06-02       Impact factor: 4.954

9.  Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood.

Authors:  Silvia Sabbioni; Elena Miotto; Angelo Veronese; Elisa Sattin; Laura Gramantieri; Luigi Bolondi; George A Calin; Roberta Gafà; Giovanni Lanza; Giuliano Carli; Eros Ferrazzi; Carlo Feo; Alberto Liboni; Sergio Gullini; Massimo Negrini
Journal:  Mol Diagn       Date:  2003

10.  The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer.

Authors:  Jian Wang; Abul Elahi; Abidemi Ajidahun; Whalen Clark; Jonathan Hernandez; Alex Achille; Ji-hui Hao; Edward Seto; David Shibata
Journal:  Cancer Biol Ther       Date:  2014-06-11       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.